Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT
Children's Hospital of Philadelphia
Children's Hospital of Philadelphia
Boston Children's Hospital
Taiho Oncology, Inc.
Ossium Health, Inc.
Institute of Hematology & Blood Diseases Hospital, China
Cullgen (Shanghai),Inc
Medical University of Gdansk
Ohio State University Comprehensive Cancer Center
Peter MacCallum Cancer Centre, Australia
UNC Lineberger Comprehensive Cancer Center
Affiliated Hospital of Qinghai University
Medical College of Wisconsin
Sanguine Biosciences
Universitaire Ziekenhuizen KU Leuven
Hospital Universitari Vall d'Hebron Research Institute